BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance

AMSTERDAM, May 24, 2018 /PRNewswire/ -- BioGX B.V. continues its *BD MAX™  menu expansion with the launch of six additional CE-Mark infectious disease tests on Becton, Dickinson and Company's BD MAX™ Sample-to-Answer platform.  This brings the company's CE-Mark menu for the BD MA...

from PR Newswire: //https://ift.tt/2x7W369